Outscourcing model

—The pharmaceutical industry is changing rapidly, in an attempt to decrease fixed costs companies have been closing discovery sites and have been moving to an outsourcing model.

There is a greater focus on using smaller discovery focused companies as the source for either discovery or early development candidate drugs.

We can provide confidential impartial independent advice on CRO selection, study designs, and data interpretation.